CB Therapeutics

Growth Stage

Advanced synthetic biology for planet and human health

Overview

Raised to Date: Raised: $10,650

Total Commitments ($USD)

Platform

Republic

Start Date

02/28/2023

Close Date

04/30/2023

Min. Goal

$25,000

Max. Goal

$1,235,000

Min. Investment

$250

Security Type

SAFE

Series

Series B

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$45,000,000

Discount

20%

Rolling Commitments ($USD)

Status

Active

Reporting Date

03/27/2023

Days Remaining

34

% of Min. Goal

43%

% of Max. Goal

1%

Likelihood of Max
unlikely
Avg. Daily Raise

$394

# of Investors

32

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Carlsbad, California

Business Type

Growth

CB Therapeutics, with a valuation of $45 million, is raising funds on Republic. The company has developed an advanced synthetic biology and cellular agriculture platform. The platform aims to discover, develop, and produce compounds to solve problems in the field of healthcare, food, mental health, and the environment. CB Therapeutics has a substantial patent portfolio with seven granted and 13 pending patents and has been generating revenues since 2022. She Ali Butt and Jacob Vogan founded CB Therapeutics in March 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for small-scale manufacturing, hiring of laboratory personnel, and research and development.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$2,014,066

$0

COGS

$0

$0

Tax

$3,017

$1,600

 

 

Net Income

$-1,772,158

$-2,278,343

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,810,709

$13,453

Accounts Receivable

$14,066

$0

Total Assets

$3,722,376

$910,015

Short-Term Debt

$287,110

$677,795

Long-Term Debt

$188,555

$730,988

Total Liabilities

$475,665

$1,408,783

Financials as of: 02/28/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Are you the founder of CB Therapeutics? Create your account today to claim this raise page.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CB Therapeutics on Republic 2023
Platform: Republic
Security Type: SAFE
Valuation: $45,000,000

Follow company

Follow CB Therapeutics on Republic 2023
View on Republic